Physician profile
Olumuyiwa O Adeboye
NPI 1720261407
$2,366.73
in general payments reported to CMS, 2019-2025
41 companies · $972 in 2025
The $972 reported for 2025 was more than what 95% of Hospice and Palliative Medicine (Internal Medicine) providers received nationally (typical 2025 total: $77.77).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $86.54 · 2023: $352 · 2024: $956 · 2025: $972.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,250 · Education: $30.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,249.54 |
| Education | $30.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $242.51 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Daiichi Sankyo INC. | $228.25 | 2023-2025 | Enhertu, Vanflyta |
| Novartis Pharmaceuticals Corporation | $204.97 | 2024-2025 | |
| Astrazeneca Pharmaceuticals Lp | $126.09 | 2023-2025 | Lynparza, Calquence, Imfinzi |
| Pfizer INC. | $111.70 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $109.61 | 2023-2024 | Ninlaro, Alunbrig |
| Janssen Biotech, INC. | $102.51 | 2023-2025 | Rybrevant, Darzalex, Tecvayli |
| Jazz Pharmaceuticals INC. | $87.37 | 2023-2025 | Zepzelca |
| Sobi, INC | $80.18 | 2024-2025 | |
| Eisai INC. | $66.87 | 2022-2025 | |
| Stemline Therapeutics INC. | $66.28 | 2023-2025 | Orserdu, Elzonris |
| Incyte Corporation | $61.54 | 2022-2025 | Jakafi, Zynyz, Monjuvi |
| Lilly USA, LLC | $57.59 | 2024-2025 | Jaypirca, Retevmo, Verzenio |
| Glaxosmithkline, LLC. | $52.21 | 2023-2025 | Ojjaara, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.36 | 2023-2024 | Gilotrif |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olumuyiwa Adeboye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.